Search Results 1301-1310 of 18411 for Immunode

1. A Study to Evaluate Trabectedin with Olaparib in Advanced Unresectable or Metastatic Sarcoma - Mayo Clinic

   Immunocompromised patients; e.g., patients who are known to be serologically positive for human immunodeficiency virus (HIV). Patients with known active ...

2. A Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination with Rituximab in Participants With Refractory Large B-Cell Lymphoma (ZUMA-14) - Mayo Clinic

   Primary immunodeficiency History of autoimmune disease (e.g., Crohn's, rheumatoid arthritis, systemic lupus) resulting in end organ injury or requiring ...

3. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

   Known human immunodeficiency virus (HIV/acquired immunodeficiency syndrome [AIDS]) infection as further severe immunosuppression with this regimen may occur.

4. An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia - Mayo Clinic

   ... , or mannitol. Human immunodeficiency virus (HIV) infection or an active and uncontrolled infection with hepatitis C virus (HCV) or hepatitis B virus (HBV).

5. Publications - Pierre Noel, M.D. - Mayo Clinic

   Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica ...

6. Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy - Mayo Clinic

   Known history of positive test result for human immunodeficiency virus. Known history of positive test result for hepatitis C virus antibody or hepatitis B ...

7. Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 - Mayo Clinic

   B, hepatitis C, or human immunodeficiency virus (HIV) will be excluded. 6. Participants who, in the opinion of the investigator, may not be able to comply ...

8. A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF - Mayo Clinic

   Known history of human immunodeficiency virus (HIV) infection, active chronic hepatitis B (e.g., hepatitis B surface antigen positive), and/or untreated ...

9. A Study to Evaluate the Effectiveness, Safety, and Tolerability of TAK-935 as an Adjunctive Therapy in Pediatric Patients with Developmental and/or Epileptic Encephalopathies - Mayo Clinic

   History of human immunodeficiency virus (HIV) infection (patient who has tested positive for human immunodeficiency virus antibodies (HIV)-1/2Ab), or ...

10. VG161 in the Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma - Mayo Clinic

    Known to test positive for human immunodeficiency virus (HIV) or syphilis. 11. Active infection including hepatitis B (HBV) or hepatitis C (HCV) that ...